about
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the ful...
Read More
19.00
0.19
(1.01%)
489.0K
XNAS Volume
XNAS 01 Oct, 2025 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Septerna Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..